News Center

With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.

25

2025

-

08

Linuo Pharmaceutical holds business etiquette training to enhance employees' professional qualities and brand image!

Classification:

行业新闻

Corporate News

Staff Style


To further enhance employees' professional qualities and shape a professional and appropriate corporate image, Linuo Pharmaceutical recently organized a special training activity on business etiquette, attracting active participation from employees across various departments. Through systematic learning and interactive practice, the awareness of etiquette norms in business settings was comprehensively strengthened.

 

 

This training specially invited a senior etiquette instructor from the group to conduct the course, covering aspects such as appearance and grooming, seating etiquette, reception etiquette, and dining etiquette. The instructor combined the characteristics of business interactions in the pharmaceutical industry, using theoretical explanations, case analyses, and on-site simulations to provide employees with a detailed interpretation of business etiquette norms, helping them master practical etiquette skills.

Business etiquette reflects a company's soft power. Employees who participated in the training expressed that the course was full of valuable content and that they will apply the knowledge learned to their actual work, demonstrating Linuo Pharmaceutical employees' professional qualities in business negotiations, client receptions, and other scenarios. The company will continue to carry out such training in the future, using etiquette norms as a starting point to promote corporate culture construction and brand image upgrading, making every employee a "living business card" for Linuo. "Living business card."

 

Related news

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

2026-05-18

On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.

Dual Exhibitions, Full-Chain Collaboration | Keyuan Pharmaceutical, together with its subsidiary Linuo Pharmaceutical, proudly showcases its offerings at the Shanghai International Pharmaceutical Dual Exhibitions!

Dual Exhibitions, Full-Chain Collaboration | Keyuan Pharmaceutical, together with its subsidiary Linuo Pharmaceutical, proudly showcases its offerings at the Shanghai International Pharmaceutical Dual Exhibitions!

2026-05-13

On May 13, the 92nd National Pharmaceutical Fair and the 94th China International API, Intermediate, Packaging & Equipment Exhibition (API China) opened in grand style at the Shanghai National Exhibition and Convention Center. As an innovative, publicly listed company in China’s chemical pharmaceutical sector, Shandong Keyuan Pharmaceutical Co., Ltd. (301281.SZ), together with its wholly owned subsidiary Shandong Linuo Pharmaceutical Co., Ltd., made a high‑profile appearance, showcasing a coordinated approach to APIs and finished dosage forms, a comprehensive end-to-end product portfolio, and strong brand synergy. The company highlighted its robust capabilities in innovative R&D, digital and intelligent manufacturing, green production, global supply chains, and clinical translation, while engaging domestic and international partners to explore emerging industry trends, expand new avenues of collaboration, and co‑create a thriving new ecosystem for the pharmaceutical and healthcare sectors.

Guided by the principle of “the entire organization as one cohesive unit, with the entire camp operating under a single command,” Keyuan Pharmaceutical’s subsidiary ushers in a new chapter in strategic implementation.

Guided by the principle of “the entire organization as one cohesive unit, with the entire camp operating under a single command,” Keyuan Pharmaceutical’s subsidiary ushers in a new chapter in strategic implementation.

2026-05-07

On May 6, Lino Pharmaceutical, a subsidiary of Keyuan Pharmaceutical (stock code: 301281.SZ), held a company-wide meeting in Jinan. Centered on the core principle of “unified strategy across the entire workforce and coordinated action across all business units,” the meeting comprehensively communicated the company’s development strategy and outlined the implementation roadmap, aligning the thinking and building consensus among all employees. With a spirit of concerted effort and synchronized momentum, the meeting charted a new blueprint for the company’s high-quality development.

Great news! First prize!

Great news! First prize!

2026-05-07

Recently, the Jinan Municipal Federation of Trade Unions officially announced the list of winners for the 2025 “Making Contributions in the Spring City” Innovation and Excellence Labor Competition. Shandong Linuo Pharmaceutical Co., Ltd.’s Solid Dosage Form Workshop stood out among numerous outstanding work teams across the city thanks to its remarkable performance, rigorous work style, and exceptional innovative capabilities, earning the prestigious First Prize for Work Teams.